menu_classic.png
COUNTRY SELECTOR
enZA

 

 

PHARMACOLOGICAL CLASSIFICATION:

A.22. 1.4 - Vitamins: Others

 

INDICATIONS:

NEUROBION tablets are indicated where a deficiency of the relevant vitamins exists.

 

CONTRA-INDICATIONS:

NEUROBION should not be used in patients on Levodopa therapy.

Hypersensitivity to any of the above ingredients.

 

DOSAGE AND DIRECTIONS FOR USE:

NEUROBION tablets may be administered in a dosage of 1 daily.

 

SIDE-EFFECTS AND SPECIAL PRECAUTIONS:

Cyanocobalamin should not be given before a diagnosis has been fully established because of the possibility of masking

symptoms of subacute degeneration of the spinal cord.

Cyanocobalamin is not a suitable form of vitamin B12 for the treatment of optic neuropathies associated with raised

plasma concentrations of cyanocobalamin.

 

KNOWN SYMPTOMS OF OVERDOSAGE AND PARTICULARS OF ITS TREATMENT:

Treatment is symptomatic and supportive.

 

IDENTIFICATION:

White, shiny, round coated tablets, steeply convexed on both sides.

 

PRESENTATION:

Amber glass bottles containing 30 tablets.

 

STORAGE INSTRUCTIONS:

Store at or below 25 ·c.

 

KEEP OUT OF REACH OF CHILDREN.

 

REFERENCE NUMBER:

H2487 (Act 101/1965).

 

NAME AND BUSINESS ADDRESS OF THE APPLICANT:

Merck (Pty) Ltd

1 Friesland Drive

Longmeadow Business Estate South

Modderfontein, 1645

 

DATE OF PUBLICATION OF THIS PACKAGE INSERT:

11 March 1988

PACKAGE INSERT


You are about to leave the Neurobion® South African website and will be redirected to an external website. Would you like to leave?